GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders
Marijuana Stocks, Finance, & InvestingUncategorized October 8, 2021 MJ Shareholders
A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder (PTSD)—the latest example of how the psychedelics reform movement is gaining momentum.
Led by Rep. Tracy Pennycuick (R), the legislation, titled the Public Heath Benefits of Psilocybin Act, would establish “a framework for research in this Commonwealth to discover innovative methods to optimize the public health benefits of psilocybin.” It would prioritize studies that focus on veterans, retired first responders and their families.
Under HB 1959, which was formally filed with 19 cosponsors on Wednesday, the state Department of Health would authorize at least two entities to “plant, grow and cultivate natural psilocybin mushroom product solely for use in the clinical studies of psilocybin.”
Read More
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
